Cited by 371Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Reactive astrocytes secrete lcn2 to promote neuron death

Open access
Bi, Fangfang, Huang, Cao, Tong, Jianbin, Qiu, Guang, Huang, Bo, Wu, Qinxue, Li, Fang, Xu, Zuoshang +3 more·2013·Proceedings of the National Academy of Sciences

Abstract

Glial reaction is a common feature of neurodegenerative diseases. Recent studies have suggested that reactive astrocytes gain neurotoxic properties, but exactly how reactive astrocytes contribute to neurotoxicity remains to be determined. Here, we identify lipocalin 2 (lcn2) as an inducible factor that is secreted by reactive astrocytes and that is selectively toxic to neurons. We show that lcn2 is induced in reactive astrocytes in transgenic rats with neuronal expression of mutant human TAR DNA-binding protein 43 (TDP-43) or RNA-binding protein fused in sarcoma (FUS). Therefore, lcn2 is induced in activated astrocytes in response to neurodegeneration, but its induction is independent of TDP-43 or FUS expression in astrocytes. We found that synthetic lcn2 is cytotoxic to primary neurons in a dose-dependent manner, but is innocuous to astrocytes, microglia, and oligodendrocytes. Lcn2 toxicity is increased in neurons that express a disease gene, such as mutant FUS or TDP-43. Conditioned medium from rat brain slice cultures with neuronal expression of mutant TDP-43 contains abundant lcn2 and is toxic to primary neurons as well as neurons in cultured brain slice from WT rats. Partial depletion of lcn2 by immunoprecipitation reduced conditioned medium-mediated neurotoxicity. Our data indicate that reactive astrocytes secrete lcn2, which is a potent neurotoxic mediator.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1218497110

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reactive ACM showed an expected increase in abundance of C3, lipocalin-2, and other reactivity markers.

    “we found the expected increase in abundance of C3, lipocalin-2, and other reactivity markers in reactive ACM (Figure 1e)10.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Tong J, et al. (2012) XBP1 depletion precedes ubiquitin aggregation and Golgi frag- mentation in TDP-43 transgenic rats. J Neurochem 123(3):406-416.

Cited by

Sorted by citations

Authors
Bi, F., Huang, C., Tong, J., Qiu, G., Huang, B., Wu, Q., Li, F., Xu, Z., Bowser, R., Xia, X.-G., & Zhou, H.
Affiliations
  • Thomas Jefferson University (US)
  • Stanford Medicine (US)
  • University of Massachusetts Chan Medical School (US)
  • Barrow Neurological Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2013-02-19
Volume
110
Issue
10
Pages
4069-4074
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2170485551
Cited by
371
References
40
Citations by year
2026: 23 · 2025: 24 · 2024: 42 · 2023: 40 · 2022: 33 · 2021: 38 · 2020: 38 · 2019: 22 · 2018: 18 · 2017: 17 · 2016: 14 · 2015: 26 · 2014: 25 · 2013: 10
FWCI
15.88
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS073829, NS072113, R21NS072696, R01NS072113, NS072696, NS073829)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
reactive astrocytes, neutrophil gelatinase-associated lipocalin, neurotoxicity, neuronal cell death, TDP-43, FUS, neurodegeneration, glial activation, astrocyte-neuron interaction, conditioned medium, neurodegenerative diseases
MeSH terms
Lipocalin-2, Superoxide Dismutase-1, Animals, Astrocytes, Base Sequence, DNA-Binding Proteins, Humans, Nerve Degeneration, Neurons, Neurotoxins, Recombinant Proteins, Superoxide Dismutase, Cell Death, Culture Media, Conditioned, DNA, Complementary, Animals, Genetically Modified, RNA-Binding Protein FUS, Rats, Lipocalins, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review